UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 16, 2026
Accession Number:
0001193125-26-267506
Submission Type:
POS AM
CIK:
0001348911
Company Name:
KalVista Pharmaceuticals, Inc.
File Number:
333-280759